We are excited to highlight this work from Amsterdam, which examines the reliability and usability of VideoTeleConferencing and describes a user-friendly method for monitoring cognitive decline within memory clinics! #JINS#JournalINS
🔗 Check it out! https://t.co/mlNvNXT0xt
Excited to share our official publication @jmirpub@JMIR_HF with proof-of-concept results that #smartphone#digitalphenotyping is feasible with older adults and yields clinically useful information on risk and resilience factors for aging and #ADRD
https://t.co/Z00XEi6FTX
🧠 💫 Happening next week (Jan 14th): our @CognitionPia Year in Review webinar, during which we will discus exciting highlights in #cognition and dementia research from 2024, and look ahead to 2025. We look forward to your attendance! Register using the link below. #EndAlz
Excited to share our @FraminghamStudy paper in @ANA_journals!🧠 Sex-specific links between stroke risk factors and subclinical vascular brain injury support tailored prevention strategies in aging.👇https://t.co/EjPjwiHEyA
Big thanks to @sudha_md, Alexa, Matt, @bucklr01 & team!
🔔👉@CognitionPia members, we need your input! In preparation for our @ISTAART Cognition PIA 2024 Year in Review webinar, please fill out this survey to submit publications & advancements from 2024 that you would like us to highlight. Deadline *Dec 9th*! 🙏https://t.co/dD9PWNILyW
What constitutes a clinically meaningful change in everyday functioning for individuals with Alzheimer’s disease, and how can you measure this? 📈🕵️ Sign up for the webinar below! @CognitionPia@ClinTrialsPIA@impact_ad
Really excited to host this upcoming webinar on Friday October 11 where @markdbm will present his work on measuring clinically meaningful change in daily functioning in ADRD. Link to register is below:
https://t.co/yiVL6xdU9m
@DesignDataPIA#Statistics#NeuroTwitter
This year I have been chosen as a student representative within the Executive Committee of the #cognitionPIA, in @ISTAART.
It has been a pleasure to meet the EC during the #AAIC24
I'm excited for everything we can do together!
#AAIC24: what a ride!!🎢
💜 It was so great to learn, present and discuss #Alzheimer's research with so many dear colleagues and friends! 🌎
🙏🏻 Thanks @alzassociation for making this incredible week possible!
Time to rest up now. See you in Toronto next year! 😎 #EndAlz
Multi-day learning curves (MDLCs) scores diminish ax Biomarker groups, but not uniformly. A+ status regardless of T-status is associated with diminished Digit Signs MDLCs, whereas being T+ drives worse performance on Face Name and Groceries Prices MDLCs. Good work @RoosJutten 👏
I am excited to share our work, out now in @TheLancetNeuro, showing cell-based measures of gamma-secretase activity and amyloid production predict clinical, cognitive and biomarker features in autosomal dominant AD.
Link to paper: https://t.co/iej2cBmFJo
@alzassociation#AAIC
I'll be presenting at poster #552 today #AAIC24 comparing the utility of mean vs. intraindividual variability metrics of #smartphone mobility phenotypes to predict cognition in older adults. If you're interested in #digitalphenotyping or #IIV stop by!
@TUcogneuropsych@ISTAART